Cargando…

A new nucleosomic-based model to identify and diagnose SSc-ILD

BACKGROUND: Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapid evolving interstitial lung disease (SSc-ILD), driving its mortality. Specific biomarkers associated with the evolution of the lung disease are highly needed. We aimed to identify specific biomarkers of SSc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guiot, Julien, Henket, Monique, Andre, Béatrice, Herzog, Marielle, Hardat, Nathalie, Njock, Makon-Sebastien, Moermans, Catherine, Malaise, Michel, Louis, Renaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430109/ https://www.ncbi.nlm.nih.gov/pubmed/32807242 http://dx.doi.org/10.1186/s13148-020-00915-4

Ejemplares similares

Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
por: Guiot, Julien, et al.
Publicado: (2021)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
por: Guiot, Julien, et al.
Publicado: (2022)

A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome
por: Parzibut, Gilles, et al.
Publicado: (2021)

Exosomal Long Non-Coding RNAs in Lung Diseases
por: Poulet, Christophe, et al.
Publicado: (2020)

Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis
por: Guiot, Julien, et al.
Publicado: (2023)

Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets
por: Guiot, Julien, et al.
Publicado: (2019)

Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2017)

Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p
por: Guiot, Julien, et al.
Publicado: (2020)

Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
por: Njock, Makon-Sébastien, et al.
Publicado: (2019)

Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Guiot, Julien, et al.
Publicado: (2017)

Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
por: Guiot, Julien, et al.
Publicado: (2023)

Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis
por: Guiot, Julien, et al.
Publicado: (2023)

Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer
por: Wilson-Robles, Heather, et al.
Publicado: (2020)

Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Natural variability in the disease course of SSc-ILD: implications for treatment
por: Vonk, Madelon C., et al.
Publicado: (2021)

Increased KL-6 levels in moderate to severe COVID-19 infection
por: Cambier, Maureen, et al.
Publicado: (2022)

Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
por: Denis, Anna, et al.
Publicado: (2022)

Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers
por: Jacquerie, P., et al.
Publicado: (2021)

Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
por: Guiot, J., et al.
Publicado: (2017)

The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2020)

SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: effect of Nintedanib
por: Ravanetti, Francesca, et al.
Publicado: (2021)

High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients
por: Ruaro, Barbara, et al.
Publicado: (2021)

Exploring the common pathophysiological links between IPF, SSc-ILD and post-COVID fibrosis
por: Swarnakar, Rajesh, et al.
Publicado: (2022)

Influence of CT Image Matrix Size and Kernel Type on the Assessment of HRCT in Patients with SSC-ILD
por: Balmer, Bettina D., et al.
Publicado: (2022)

Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD
por: Corhay, Jean Louis, et al.
Publicado: (2014)

Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses
por: Fields, Aislin, et al.
Publicado: (2023)

Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression
por: Cavalier, Etienne, et al.
Publicado: (2021)

Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype
por: Calmes, Doriane, et al.
Publicado: (2021)

CD4(+)LAG3(+)T cells are decreased in SSc-ILD and affect fibroblast mesenchymal transition by TGF-β3
por: Qin, Linmang, et al.
Publicado: (2023)

Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling
por: Grolleau, Emmanuel, et al.
Publicado: (2023)

Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
por: Shenoy, Padmanabha D., et al.
Publicado: (2016)

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
por: Kreuter, Michael, et al.
Publicado: (2022)

Are Volatile Organic Compounds Able to Identify Airflow Decline in Asthma?
por: Graff, Sophie, et al.
Publicado: (2021)

The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies
por: Fastrès, Aline, et al.
Publicado: (2017)

Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
por: Cheng, Henry S., et al.
Publicado: (2014)

The PH‐ILD Detection tool: External validation and use in patients with ILD
por: Parikh, Raj, et al.
Publicado: (2023)

Reproducibility of pulmonary function tests in patients with systemic sclerosis
por: Jacquerie, P., et al.
Publicado: (2023)

YKL-40 as a new promising prognostic marker of severity in COVID infection
por: Schoneveld, Lauranne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8gidj0mdlgo7tahcu4n1j118dh